Literature DB >> 18585915

The role of virulence determinants in community-associated MRSA pathogenesis.

Binh An Diep1, Michael Otto.   

Abstract

The recent emergence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) marked a quantum change in the biology and epidemiology of a major human pathogen. Various virulence determinants unique to CA-MRSA have been uncovered recently, which shed light on how these strains spread easily and sustainably among humans and frequently cause severe disease. The role of the Panton Valentine leukocidin (PVL) in CA-MRSA pathogenesis is a matter of much debate. Although epidemiological data have indicated a role for PVL in the CA-MRSA disease process, recent data from relevant animal models indicate that PVL does not impact virulence of prevalent CA-MRSA strains. Identifying specialized pathogenic traits of CA-MRSA remains a challenge that will yield new diagnostic tools and therapeutic targets for drug and vaccine development. Here, we discuss the roles of PVL, the arginine catabolic mobile element and phenol-soluble modulins in the pathogenesis of prevalent CA-MRSA strains.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18585915      PMCID: PMC2778837          DOI: 10.1016/j.tim.2008.05.002

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  70 in total

1.  Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1.

Authors:  Marisa I Gómez; Aram Lee; Bharat Reddy; Amanda Muir; Grace Soong; Allyson Pitt; Ambrose Cheung; Alice Prince
Journal:  Nat Med       Date:  2004-07-11       Impact factor: 53.440

2.  Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus.

Authors:  Binh An Diep; Heather A Carleton; Richard F Chang; George F Sensabaugh; Francoise Perdreau-Remington
Journal:  J Infect Dis       Date:  2006-04-21       Impact factor: 5.226

3.  Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia.

Authors:  Juliane Bubeck Wardenburg; Taeok Bae; Michael Otto; Frank R Deleo; Olaf Schneewind
Journal:  Nat Med       Date:  2007-12       Impact factor: 53.440

4.  Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community.

Authors:  Keiko Okuma; Kozue Iwakawa; John D Turnidge; Warren B Grubb; Jan M Bell; Frances G O'Brien; Geoffrey W Coombs; John W Pearman; Fred C Tenover; Maria Kapi; Chuntima Tiensasitorn; Teruyo Ito; Keiichi Hiramatsu
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

5.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

6.  Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils.

Authors:  Anne-Laure Genestier; Marie-Cécile Michallet; Gilles Prévost; Gregory Bellot; Lara Chalabreysse; Simone Peyrol; Françoise Thivolet; Jerome Etienne; Gérard Lina; François M Vallette; François Vandenesch; Laurent Genestier
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

7.  The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus.

Authors:  Binh An Diep; Gregory G Stone; Li Basuino; Christopher J Graber; Alita Miller; Shelley-Ann des Etages; Alison Jones; Amy M Palazzolo-Ballance; Françoise Perdreau-Remington; George F Sensabaugh; Frank R DeLeo; Henry F Chambers
Journal:  J Infect Dis       Date:  2008-06-01       Impact factor: 5.226

Review 8.  Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection.

Authors:  Loren G Miller; Binh An Diep
Journal:  Clin Infect Dis       Date:  2008-03-01       Impact factor: 9.079

9.  Methamphetamine use and methicillin-resistant Staphylococcus aureus skin infections.

Authors:  Adam L Cohen; Carrie Shuler; Sigrid McAllister; Gregory E Fosheim; Michael G Brown; Debra Abercrombie; Karen Anderson; Linda K McDougal; Cherie Drenzek; Katie Arnold; Daniel Jernigan; Rachel Gorwitz
Journal:  Emerg Infect Dis       Date:  2007-11       Impact factor: 6.883

10.  Methicillin-resistant Staphylococcus aureus clones, Western Australia.

Authors:  Geoffrey W Coombs; Julie C Pearson; Frances G O'Brien; Ronan J Murray; Warren B Grubb; Keryn J Christiansen
Journal:  Emerg Infect Dis       Date:  2006-02       Impact factor: 6.883

View more
  133 in total

1.  Antimicrobial activity of community-associated methicillin-resistant Staphylococcus aureus is caused by phenol-soluble modulin derivatives.

Authors:  Hwang-Soo Joo; Gordon Y C Cheung; Michael Otto
Journal:  J Biol Chem       Date:  2011-01-28       Impact factor: 5.157

2.  Do differences in Panton-Valentine leukocidin production among international methicillin-resistant Staphylococcus aureus clones affect disease presentation and severity?

Authors:  Eve Boakes; Angela M Kearns; Cederic Badiou; Gerard Lina; Robert L Hill; Matthew J Ellington
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

Review 3.  Novel targeted immunotherapy approaches for staphylococcal infection.

Authors:  Michael Otto
Journal:  Expert Opin Biol Ther       Date:  2010-07       Impact factor: 4.388

4.  Distinct bacteriophages encoding Panton-Valentine leukocidin (PVL) among international methicillin-resistant Staphylococcus aureus clones harboring PVL.

Authors:  E Boakes; A M Kearns; M Ganner; C Perry; R L Hill; M J Ellington
Journal:  J Clin Microbiol       Date:  2010-11-24       Impact factor: 5.948

5.  Staphylococcus aureus α-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome.

Authors:  Chahnaz Kebaier; Robin R Chamberland; Irving C Allen; Xi Gao; Peter M Broglie; Joshua D Hall; Corey Jania; Claire M Doerschuk; Stephen L Tilley; Joseph A Duncan
Journal:  J Infect Dis       Date:  2012-01-25       Impact factor: 5.226

6.  The virulence regulator Agr controls the staphylococcal capacity to activate human neutrophils via the formyl peptide receptor 2.

Authors:  Dorothee Kretschmer; Nele Nikola; Manuela Dürr; Michael Otto; Andreas Peschel
Journal:  J Innate Immun       Date:  2011-11-08       Impact factor: 7.349

7.  SaeR binds a consensus sequence within virulence gene promoters to advance USA300 pathogenesis.

Authors:  Tyler K Nygaard; Kyler B Pallister; Peter Ruzevich; Shannon Griffith; Cuong Vuong; Jovanka M Voyich
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

8.  Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin.

Authors:  Kerry J Welsh; April N Abbott; Evan M Lewis; Jeanelle M Gardiner; Mark C Kruzel; Cole T Lewis; John F Mohr; Audrey Wanger; Lisa Y Armitige
Journal:  J Clin Microbiol       Date:  2010-01-20       Impact factor: 5.948

9.  RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus.

Authors:  Shu Y Queck; Max Jameson-Lee; Amer E Villaruz; Thanh-Huy L Bach; Burhan A Khan; Daniel E Sturdevant; Stacey M Ricklefs; Min Li; Michael Otto
Journal:  Mol Cell       Date:  2008-10-10       Impact factor: 17.970

10.  A point mutation in the agr locus rather than expression of the Panton-Valentine leukocidin caused previously reported phenotypes in Staphylococcus aureus pneumonia and gene regulation.

Authors:  Amer E Villaruz; Juliane Bubeck Wardenburg; Burhan A Khan; Adeline R Whitney; Daniel E Sturdevant; Donald J Gardner; Frank R DeLeo; Michael Otto
Journal:  J Infect Dis       Date:  2009-09-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.